Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment-Reference-Cited by-同舟云学术

Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment

Published:2022-09-15 Issue:18 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Grudda Tanner^ORCID,Hwang Hyon S.^ORCID,Taddese Maraake^ORCID,Quinn Jeffrey^ORCID,Sulkowski Mark S.^ORCID,Sterling Richard K.,Balagopal Ashwin,Thio Chloe L.^ORCID

Funder

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/161818/files/pdf

Reference30 articles.

1. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely

2. Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors

3. Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

4. Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

5. WHO. Global Progress Report on HIV, Viral Hepaitis and Sexually Transmitted Infections, 2021. https://www.who.int/publications/i/item/9789240027077 Updated July 15, 2021. Accessed July 6, 2022

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and genotyping techniques in diagnosis of Coxiella burnetii: An overview;Infection, Genetics and Evolution;2024-09

2. Detection of HBV DNA integration in plasma cell-free DNA of different HBV diseases utilizing DNA capture strategy;Virologica Sinica;2024-08

3. Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV Coinfection;Pathogens and Immunity;2024-07-30

4. Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein;Antimicrobial Agents and Chemotherapy;2024-07-09

5. Hepatitis B Surface Antigen Loss: What Does Integration Have to Do With a Functional Hepatitis B Virus Cure?;The Journal of Infectious Diseases;2024-06-24